Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.66, No.3, p.470-480, 2019 |
||
Title: APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis | ||
Author: Z. J. Bai, Q. Liu, X. S. Wang, W. Y. Liu | ||
Abstract: The clinical role of APC promoter methylation in patients with bladder cancer remains to be determined. The relevant databases (PubMed, EMBASE, EBSCO, WANFANG DATA, CNKI and Cochrane Library) were searched to get eligible studies. The overall odds ratios (ORs) and the corresponding 95% confidence intervals (95% CIs) were calculated to assess the effects of APC promoter methylation on bladder cancer risk and clinicopathological features. 2214 patients with bladder cancer and 665 controls were identified. APC promoter methylation was significantly higher in bladder cancer than in non-malignant tissue and urine samples (tissue: OR=11.14, 95% CI=4.29–28.91, p |
||
Keywords: APC, methylation, bladder cancer, urine, biomarker, prognosis | ||
Published online: 28-May-2019 | ||
Year: 2019, Volume: 66, Issue: 3 | Page From: 470, Page To: 480 | |
doi:10.4149/neo_2018_181009N753 |
||
|
download file |
|